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ABSTRACT
Background: Immunoglobulin A nephropathy (IgAN) with 
nephrotic syndrome is an uncommon form of  IgAN. Clinical and 
morphological characteristics of  proteinuria in IgAN, especially 
when is in nephrotic range have not yet been fully examined. 
This study was aimed to correlate morphologic variables of  the 
Oxford classification, and various clinical data with proteinuria 
in IgAN patients. We also aimed to demonstrate the significance 
of  prevention of  proteinuria as one of  the important factors in 
progression of  this disease.
Methods: In an observational study conducted on IgAN patients, 
total of  114 biopsies were entered in the study. IgAN was diagnosed 
by light and immunofluorescence study.
Results: Of  114 patients 70.2% were male. Mean age of  patients was 
37.7 ± 13.6 years. The mean of  proteinuria was 1742 ± 1324 mg/day. 
Also mean of  serum creatinine (Cr) was 1.6 ± 1.5 mg/dL. Of  
114 patients, 11(9.6%) had nephrotic range proteinuria. In this 
study, there was a positive correlation between proteinuria and 
serum Cr, peri-glomerular fibrosis or interstitial fibrosis. There 
was a positive association between proteinuria and totally sclerotic 
glomeruli too. There was also a positive association between the 
amount of  fibrous crescents and the level of  proteinuria. Nephrotic 
proteinuria could just be seen in male patients. Also, nephrotic 
syndrome had a positive association with the number of  crescents.
Conclusions: Our findings firstly support the prognostic value of  
crescent due to its association with proteinuria and secondly imply 
the importance of  treatment of  proteinuria to prevent progression 
of  IgAN.
Keywords: Crescent, immunoglobulin A nephropathy, nephrotic 
syndrome, Oxford classification, proteinuria
INTRODUCTION
Immunoglobulin A nephropathy (IgAN) is an autoimmune 
disease and is very common form of primary glomerulonephritis.[1-4] It
occurs worldwide with different frequency from 2% to 52% of  
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all renal diseases in different parts of  the world.[1-9] 
Proteinuria >1.0 g/day, at diagnosis is a well-known 
indicator of  progressive renal disease in patients with 
IgAN.[9-17] Indeed persistent proteinuria exceeding 
this amount is an independent predictor of  
subsequent renal progression in patients with IgAN 
who have been followed for 10 years or more.[17-21] 
Nephropathy of  IgA with nephrotic syndrome is an 
uncommon form of  IgAN.[3,5,18-20] The clinical and 
morphological characteristics of  this condition have 
not yet been understood. In IgAN, urinary findings 
usually consist of  mild-to-moderate proteinuria 
and hematuria, and it rarely presents with a 
proteinuria in nephrotic range. The prevalence of  
IgAN with nephrotic syndrome (nephrotic IgAN; 
nIgAN), varies from 5% to 20%[18-25] The Oxford 
classification, created in 2009, is a novel method 
for evaluation of  histological findings of  IgAN.[23-28] 
This classification has good reproducibility and 
can be used to evaluate prognosis and response 
to therapy. This study was aimed to correlate four 
morphologic variables of  the Oxford classification, 
and the various clinical data with proteinuria in 
IgAN patients. We also aimed to demonstrate, the 
significance of  prevention of  proteinuria as one of  
the important factors in progression of  this disease.
METHODS
Following popularization of  Oxford 
classification of  IgA N on July 2009,[26-28] we applied 
it in this study for the classification of  IgAN.
Definition of IgAN
The pathologic diagnosis of  IgAN requires 
demonstration of  IgA-dominant mesangial or 
mesangial-capillary immune deposits through 
immune fluorescence(IF) microscopy while there 
is subdominant, or weak deposit for C
1
q. The 
immune deposits were semi quantified from 0 to 
3+positive bright. The definition of  IgAN needs 
the presence of  diffuse and global IgA deposits that 
were graded ≥2+ and weak C
1
q deposition.[5,29-31] 
All renal biopsies, performed at various medical 
centers (University Hospitals or Private Centers) 
from July 2009 to July 2012, were sent to a reference 
laboratory. None of  the patients was treated before 
the biopsy. Biopsies with less than eight glomeruli 
were excluded from the study. None of  the patients 
was diagnosed as primary IgAN, having a history 
of  collagen vascular diseases, diabetes or liver 
cirrhosis based on a questionnaire filled at the time 
of  biopsy admission, laboratory data in patients’ 
records and a brief  history provided by referee 
physicians at the time of  biopsy admission.
Histologic data
All renal biopsies were prepared for light and 
direct immunofluorescence microscopy. Tissue 
was fixed in 10% formalin for histologic sectioning. 
Each kidney biopsy was prepared by cutting paraffin 
blocks into 3-μm sections and staining two slides 
with periodic acid Schiff, two slides for hematoxylin 
and eosin, one slide for Jones methenamine silver 
and one slide for trichrome. Each slide contained 
2-3 sections and nap-frozen in liquid nitrogen was 
used for IF. Sections (Six-micron in thickness) were 
stained for immunofl uorescence study with IgG, 
IgM, IgA, C1q, C3, and find 1q.[32-34] IF slides were 
reported in a scale of  0-3+ positive bright and by a 
nephropathologist. IF study was performed before 
reviewing the slides for light microscopy unaware 
of  patients’ data. After IF diagnosis of  IgAN, 
histopathology glass slides were reviewed to assess 
the morphologic variables, which were applied in 
Oxford classification method. We also assessed the 
presence of  extracapillary proliferation (cellular, 
fibro-cellular or fibrous crescents). After selection 
of  biopsies having dominant deposition IgA by IF 
study and in the absence of  exclusion criteria, glass 
slides were reported for the classification of  
Oxford-MEST.
Definitions of morphologic variables
Total glomeruli and the number of  glomeruli 
with global sclerosis were recorded for each biopsy. 
The presence of  (i) mesangial hypercellularity(M), 
(ii) endocapillary proliferation(E), (iii) segmental 
glomerulosclerosis (S) and (iv) the proportion 
of  tubular atrophy and interstitial fibrosis; 
IF/TA(T) was estimated as published for Oxford 
classification.[29]
Clinical studies and laboratory data
The medical records of  patients were reviewed to 
obtain various demographic, clinical and laboratory 
information at the time of  biopsy and for follow-
up activities. Data gathered at the time of  biopsy 
included race, gender, age, serum creatinine (Cr) 
and proteinuria (based on a 24 h urine collection).
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Statistical analysis
The mean values and standard deviations 
were calculated, and statistical significance of the 
differences between groups were evaluated using 
T and Likelihood Ratio tests. Because of high 
positive skewness of data, the Spearman’s coefficient 
of correlation was used to check the correlation. 
A computer program (SPSS version 16.0, Chicago, 
IL, USA) was used for statistical analysis. P < 0.05 
was considered as statistically significant.
RESULTS
This observational study was conducted on IgAN 
patients. A total of  114 biopsies were enrolled to the 
study. In this trial, out of  114 patients, 70.2% were 
male. Mean age of  patients was 37.7 ± 13.6 years 
(median = 35 years) (39 ± 14.3 years for male and 
35 ± 11.7 years for female patients). Morphologic 
variables of  Oxford classification are summarized 
in Table 1. The mean of  proteinuria was 
1742 ± 1324 mg/day (median = 1500 mg/day). The 
mean number of  glomeruli in all renal biopsies 
was 14.8 ± 7.2 (median = 13 number). In all 
biopsies, the mean of  totally sclerotic glomeruli 
was 2.4 ± 2.9 (median = 1 number). Furthermore, 
the mean of  serum Cr was 1.6 ± 1.5 mg/dL 
(median = 1.2 mg/dL). Of  114 patients, 11 (9.6%) 
had nephrotic range proteinuria. In this study, there 
was a positive correlation between proteinuria and 
serum Cr (P < 0.001), peri-glomerular fibrosis 
(P = 0.013) or interstitial fibrosis (P = 0.037 Figure 1). 
There was a positive association between proteinuria 
and totally sclerotic glomeruli (P = 0.008). Off  
our variables of  Oxford classification, only M 
(mesangial proliferation ≥50% of  glomeruli) 
(P < 0.01) and T(interstitial fibrosis and tubular 
atrophy; IF/TA) (P < 0.007) had a positive 
association with proteinuria. There was a positive 
correlation between the amount of  fibrous crescents 
and the level of  proteinuria (P = 0.028). None off  
our deposited immune reactants (IgA, IgG, IgM and 
C3) had a significant association with proteinuria 
(P > 0.05). Nephrotic range proteinuria was only 
seen in male patients (P < 0.05). Furthermore, 
nephrotic syndrome had a positive association with 
the number of  crescents (P < 0.05).
DISCUSSION
After publication of IgAN classifi cation (Oxford)
on July 2009,[29-31] the various studies were conducted 
to better fi nd the clinical signifi cance of each of 
four variables. In this study, we aimed to correlate 
proteinuria, especially in the nephrotic range, with 
Oxford classifi cation. The present investigation 
showed that off our variables of Oxford classifi cation 
only M variable (mesangial proliferation ≥50% 
of glmeruli) and T (interstitial fi brosis and tubular 
atrophy; IF/TA) had a positive association with 
p=0.037
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Figure 1: Positive association of proteinuria with interstitial 
fi brosis
Table 1: Clinical and histological fi ndings of IgAN patients 
at the time of renal biopsy
Clinical fi ndings
Sex (male/female) 80/34
Age (years) 37.7±13.6 (total)
(M: 39±14.3, F: 35±11.7)
S-Cr (mg/dl) 1.6±1.5 (total)
(M: 1.8±1.7, F: 1.1±0.7)
Histological fi ndings 
(Oxford classifi cation)
Mesangial hypercellularity
M0/M1 (number) 41/73
Endocapillary hypercellularity
E0/E1 (number) 79/35
Segmental glomerulosclerosis
S0/S1 (number) 42/72
Interstitial fi brosis/
Tubular atrophy (IF/TA)
T0/T1/T2 (number) 59/35/20
IF=Interstitial fi brosis, TA=Tubular atrophy, 
IgAN=Immunoglobulin A nephropathy
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proteinuria. There was not any signifi cant association 
between four deposited immune reactants (IgA, IgG, 
IgM, and C3) and the level of proteinuria. Study on 
patients who had nephrotic range proteinuria showed 
that, this amount of proteinuria was only seen in 
male patients. We also found a positive association 
between nephrotic range proteinuria and T variable 
of Oxford classifi cation. At the time of renal biopsy 
for diagnosis of glomerular disease, proteinuria is a 
well-known indicator of progressive renal disease 
invarious renal diseases[35-45] as well as in patients 
with IgAN.[14] In a study conducted by Donadio et al. 
on 154 IgAN patients, they found that 24-h urine 
protein was a good predictor for subsequent end-
stage renal failure.[10] Kobayashi et al. also reported 
that persistent proteinuria more than 1 g/day was the 
most reliable, independent predictor of long-term 
prognosis in Japanese patients with IgAN followed 
for 10 years or more.[14] Our study was consistent with 
the results of these reports. Furthermore, it strengthens 
its importance because this study showed the highest 
correlation with various pathologic variables that to 
the best of our knowledge were not reported, yet. 
We found a positive association between proteinuria 
and peri-glomerular fi brosis or totally sclerotic 
glomeruli. We also found a positive correlation 
between proteinuria and the number of crescents. 
Specially, among cellular, fi bro-cellular and fi brous 
crescents, only fi brous crescents had an association 
with proteinuria. In clinical point of view, we found 
nephrotic range proteinuria (nephrotic syndrome) in 
only male patients, which further support that, male 
gender is a risk factor for IgAN.[3-5] Similarly, Hwang 
et al. in a study on 125 biopsy-proven primary IgAN 
patients who had more than 1.0 g/day proteinuria at 
the fi rst assessment and underwent anti-proteinuric 
treatment, found that achievement of less than 
1.0 g/day proteinuria was important for limiting the 
loss of renal function, and relapse of proteinuria 
should be closely monitored in proteinuric IgAN.[46] 
The various studies have described that the natural 
courses and prognostic factors for IgAN patients are 
progressed to end-stage renal disease.[17,46-50] In these 
studies, the worst prognosis for nephropathy of IgA 
was overt proteinuria, renal impairment and high 
grades of histological classifi cation. However, of these 
prognostic factors, proteinuria is the most important 
factor requiring the treatment in IgAN patients.[17,46-50] 
This fi nding suggests that reducing these verity of 
proteinuria in the longterm seems to be the most 
important for limiting the loss of renal function 
in proteinuric IgAN.[17-21,51-55] Kim et al. conducted 
amulti center observational study on 1076 patients 
with biopsy-proven IgAN from four medical centers 
in Korea. Of 1076 patients, 100 presented with 
nephrotic syndrome. They showed that the prognosis 
of nephrotic syndrome in IgAN was not favorable.[56] 
In the present study, we showed a positive association 
between proteinuria and M as well as T variables of the 
Oxford classifi cation in IgAN. Furthermore, out off 
our variables, we also showed a positive association 
between proteinuria and the number of crescents 
especially fi brous crescent.[57-61] Our fi ndings fi rstly 
support the prognostic value of crescent due to its 
association with proteinuria and secondly imply the 
importance of treatment of proteinuria to prevent 
progression of IgAN.
Limitation of the study
We cannot follow the patients.
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